Merck (NYSE: MRK) recently released its first-quarter results, surpassing Wall Street’s expectations for both revenue and earnings. The company reported revenue of $15.53 billion and adjusted earnings per share of $2.22, exceeding consensus estimates of $15.31 billion and $
https://www.nasdaq.com/articles/whats-next-merck-after-q1-beat